The mGlu2 receptor plays a critical role in the effectiveness of ketamine for treating depression.
A new study suggests that dysregulation in the way two G protein-coupled receptors talk to each other may be responsible for some symptoms of schizophrenia.
Brief periods of brain plasticity can provide opportunities to recover from stress disorders, researchers report.
New research could lead researchers to a better understanding of the development of psychiatric disorders such as depression and anxiety.